Leading article: A tale of two viruses
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.In recent years, the Nobel Prize for medicine has gone to eminent scientists recognised for important but, to the layman, arcane discoveries related to cell functioning and mouse genetics. Not this year. Everyone knows the devastation wreaked by Aids and the deadly potential of cervical cancer. The two French researchers who discovered the HIV virus, and the German scientist who identified the human papilloma virus (HPV) as the cause of cervical cancer, are certain to be popular recipients of the award.
Their work has saved millions of lives. But the outcome of the two discoveries has been very different. While both were made in the 1980s, and we now have a vaccine against HPV (to be rolled out in the UK this year), we are as far away as ever from a vaccine against HIV. Françoise Barre-Sinoussi admitted yesterday she and Luc Montagnier had been "naive" to think it would happen quickly. A future Nobel awaits the scientist who can crack that conundrum.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments